FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
On Monday evening, Dr. Stephen M. Hahn, director of the Food and Drug Administration, and Dr. Peter Marks, the director of the FDA's Center for Biologics Evaluation and Research (CBER), rejected a proposal from the U.S. government's Operation Warp Speed to dilute the current supply of coronavirus vaccines in order to boost supply.
During an interview on Sunday, Operation Warp Speed's chief, Dr. Moncef Slaoui, said his task force and Moderna (NASDAQ: MRNA) were in talks with the FDA about implementing the idea.
Image source: Getty Images.
Source Fool.com
